TrialTransplantation and cellular therapy2026

Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective Study.

Rachel B Salit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.